vialroom

#cagrilintide 2025-09-30

Tuesday33 messages7 participantstimes are UTC
Highlights from this day
  • quiet_head_qi — changed my mind on this, i started thinking amylin was the interesting bit and now i think its the pairing 20:17
  • juno_joins — the fullness effect hasnt faded over 13 months, unlike my semaglutide appetite curve 20:22
  • first_and_last_four — dosing them on different days made no difference i could detect, your mileage will differ 21:13
  • knees_first — back after 14 months, is monotherapy still a minority thing here 21:34
  • first_and_last_four — two PeptideMeter results on the same MKM lot came back 96.8 and 98.6, closer than i expected, from memory 22:01
QH

its an amylin analogue, different receptor family, so treating it as another GLP-1 is the first mistake

changed my mind on this, i started thinking amylin was the interesting bit and now i think its the pairing

🔥18
JJ

is the combination just the two dosed together or a single formulation

the fullness effect hasnt faded over 13 months, unlike my semaglutide appetite curve

❤️6🧊8👍14

genuine question €72 for a 20 vial and it lasts me longer than the GLP-1 does at my doses

JJ

weekly for me, same day every week, no reason beyond habit

slightly off topic but amylin analogue, so its not a GLP-1 at all right

fullness rather than nausea

stopped for 16 months and the fullness went within a fortnight of the last dose, still working it out
i titrated over twice as many weeks as i did on semaglutide and that was right for me

TT

did anyone add this to an existing tirzepatide dose rather than starting both

CO

combination GI was worse than either alone for me, which is not what i had read anywhere

[edited]

slower than the others

🧪13

did the nausea feel different to you or just less

JJ

amylin is about slowed gastric emptying and satiety signalling, thats the short version and im no pharmacologist

back after 14 months, is monotherapy still a minority thing here

Cited study
Efficacy and Safety of Cagrilintide in Adults with Overweight or Obesity — Phase 2
The Lancet · 2021
Cagrilintide monotherapy, dose ranging. The combination trials came later.

separate days

monotherapy here

💀1📈1👍4
JJ

quick one i titrated over twice as many weeks as i did on semaglutide and that was right for me

TT

nobody should copy my schedule, im describing it because people asked what a slow ramp looks like

CagriSema is cagrilintide with semaglutide and REDEFINE is the trial programme around it

FA

two PeptideMeter results on the same MKM lot came back 96.8 and 98.6, closer than i expected, from memory

how do people separate which of the two is doing what in a combination

titrating dead slow

👀5

lost 46lb over 19 months on the combination and i genuinely cannot apportion it, happy to be corrected

KF

you cannot tell which of the two is doing what in a combination and i stopped pretending i could

VI

the nausea felt different rather than less, more fullness and less of the queasy wave

underwhelming honestly